Another perspective @john12
The new team had to pick up a lot of broken pieces (to say the least). It takes time to turn a company around.
That said, they now have a focussed strategy for both regulated and non-regulated products, a 510k application submitted, alliances with companies like MBridge and they got Compass across the line - all in a year when everyone was in lockdown.
I'm going to give them a bit more time. They've done the groundwork - 2021 is going to be the litmus test imo.
MERRY XMAS AND GLTAH
Ann: FDA Strategy and Regulatory Update, page-579
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
